Sandu Pharma.

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE751D01014
NSEID:
BSEID: 524703
View on BSE

INR

38.72

-0.78 (-1.97%)

BSENSE

Jan 19

BSE+NSE Vol: 332

{
  "main_header": {
    "sid": 764862,
    "name": "Sandu Pharma.",
    "stock_name": "Sandu Pharma.",
    "full_name": "Sandu Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sandu-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "38.72",
    "chg": -0.78,
    "chgp": "-1.97%",
    "dir": -1,
    "prev_price": "39.50",
    "mcapval": "37.41 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524703,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE751D01014",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "332 ",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sandu-pharma-764862-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3792887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SanduPharmaceut_mojoScore_3792887.png",
        "date": "2026-01-15 10:10:03",
        "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Sandu Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sandu-pharmaceuticals-ltd-fallingrising-3790327",
        "imagepath": "",
        "date": "2026-01-13 01:03:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Sandu Pharmaceuticals’ share price has been under pressure, having declined for two consecutive sessions, accumulating a loss of 5.49% over this period. The stock’s intraday low touched ₹37.81, marking a 5.78% drop from previous levels, signalling persistent selling interest. Despite this, the stock remains just 3.42% above its 52-week low of ₹36.76, indicating it is trading near its lowest levels in the past year.</p>\n<p>When compared to the broader market, Sandu Pharmaceuticals has underperformed significantly on the day, lagging its sector by nearly 6%. This underperformance is particularly stark against the Sensex, which has shown modest gains over the past week and year-to-date, while Sandu’s returns have been mixed. For instance,..."
      },
      {
        "title": "Sandu Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharmaceuticals-ltd-is-rated-strong-sell-3771273",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharmaceut_mojoScore_3771273.png",
        "date": "2025-12-26 15:12:03",
        "description": "Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.36.76 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3676-3756336",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharmaceut_priceRelatedfactors_3756336.png",
        "date": "2025-12-11 10:00:18",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.36.76, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sandu Pharma. Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sandu-pharma-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3750189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SanduPharma_mojoScore_3750189.png",
        "date": "2025-12-07 10:10:03",
        "description": "Sandu Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, underscoring the complexities faced by the stock in recent periods."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3701-3735027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanduPharmaceut_priceRelatedfactors_3735027.png",
        "date": "2025-11-28 09:48:44",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid broader market activity. The stock’s performance contrasts with the overall positive trend in the Sensex, highlighting ongoing challenges within the company’s financial and operational metrics."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Continued Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3701-3735029",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanduPharmaceut_priceRelatedfactors_3735029.png",
        "date": "2025-11-28 09:48:30",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.21 Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-hits-52-week-low-amidst-continued-downtrend-3729278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanduPharmaceut_priceRelatedfactors_3729278.png",
        "date": "2025-11-25 15:42:29",
        "description": "Sandu Pharmaceuticals touched a fresh 52-week low of Rs.37.21 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.21 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sandu-pharmaceuticals-stock-falls-to-52-week-low-of-rs3721-3729276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SanduPharmaceut_priceRelatedfactors_3729276.png",
        "date": "2025-11-25 15:42:28",
        "description": "Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.21 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock has experienced a notable downward trend over the past three days, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 82,
    "sid": "764862",
    "stock_news_url": "https://www.marketsmojo.com/news/sandu-pharmaceuticals-764862"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jan-2026",
      "details": "Certificate under Regulation 74(5) of SEBI (DP) Regulation 2015 for Q ended 31.12.2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "24-Dec-2025",
      "details": "Intimation about the closure of trading window for Q ended 31st December 2025",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30-Notice Intimating Discrepancies By Government Of Maharashtra Department Of Goods And Service Tax-Office Of The Deputy Commissioner Of The State Of Goa",
      "datetime": "22-Dec-2025",
      "details": "intimation about the Notice Pertaining to discrepancies by Government of Maharashtra department of Goods and service Tax",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sandu Pharmaceuticals Ltd has declared <strong>8%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2026-01-15 10:10:03

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Sandu Pharmaceuticals Ltd falling/rising?

2026-01-13 01:03:27

Recent Price Movement and Market Context

Sandu Pharmaceuticals’ share price has been under pressure, having declined for two consecutive sessions, accumulating a loss of 5.49% over this period. The stock’s intraday low touched ₹37.81, marking a 5.78% drop from previous levels, signalling persistent selling interest. Despite this, the stock remains just 3.42% above its 52-week low of ₹36.76, indicating it is trading near its lowest levels in the past year.

When compared to the broader market, Sandu Pharmaceuticals has underperformed significantly on the day, lagging its sector by nearly 6%. This underperformance is particularly stark against the Sensex, which has shown modest gains over the past week and year-to-date, while Sandu’s returns have been mixed. For instance,...

Read full news article

Sandu Pharmaceuticals Ltd is Rated Strong Sell

2025-12-26 15:12:03

Sandu Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 September 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 December 2025, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.36.76 Amidst Continued Underperformance

2025-12-11 10:00:18

Sandu Pharmaceuticals has reached a new 52-week low of Rs.36.76, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sandu Pharma. Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-07 10:10:03

Sandu Pharma., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. This shift follows a detailed reassessment of the company’s quality, valuation, financial trends, and technical indicators, underscoring the complexities faced by the stock in recent periods.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Market Pressure

2025-11-28 09:48:44

Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid broader market activity. The stock’s performance contrasts with the overall positive trend in the Sensex, highlighting ongoing challenges within the company’s financial and operational metrics.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.01 Amidst Continued Underperformance

2025-11-28 09:48:30

Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.01 today, marking a significant decline in its stock price amid ongoing challenges in its financial performance and market positioning within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.21 Amid Continued Downtrend

2025-11-25 15:42:29

Sandu Pharmaceuticals touched a fresh 52-week low of Rs.37.21 today, marking a significant decline amid a sustained downward trend. The stock has recorded losses over the past three consecutive sessions, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Read full news article

Sandu Pharmaceuticals Falls to 52-Week Low of Rs.37.21 Amid Market Pressure

2025-11-25 15:42:28

Sandu Pharmaceuticals has reached a new 52-week low of Rs.37.21 today, marking a significant decline amid broader market fluctuations and sector underperformance. The stock has experienced a notable downward trend over the past three days, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector.